Efficacy, safety and therapeutic mechanism of Shen-Qi Xiao-Tan formula in the treatment of peripheral atherosclerosis in patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial protocol.

Yulin LengXiaoxu FuLisen QianQiqi LiHong GaoHongyan XieChun-Guang Xie

Published in: BMC complementary medicine and therapies (2022)

This trial is registered on Chinese Clinical Trials.gov with number ChiCTR2100047189 on 10 Jun 2021, and has been approved by the Ethical Review Committee of Hospital of Chengdu University of Traditional Chinese Medicine with number 2020KL-080.

Keyphrases

clinical trial
double blind
phase iii
phase ii
study protocol
placebo controlled
randomized controlled trial
open label
cardiovascular disease
healthcare
combination therapy
type diabetes
acute care
emergency department
adverse drug
drug administration